Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

Published:2016-01 Issue:1 Volume:31 Page:16-35
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Adler Robert A¹,El-Hajj Fuleihan Ghada²,Bauer Douglas C³,Camacho Pauline M⁴,Clarke Bart L⁵,Clines Gregory A⁶,Compston Juliet E⁷,Drake Matthew T⁵,Edwards Beatrice J⁸,Favus Murray J⁹,Greenspan Susan L¹⁰,McKinney Ross¹¹,Pignolo Robert J¹²,Sellmeyer Deborah E¹³

Affiliation:

1. McGuire Veterans Affairs Medical Center and Virginia Commonwealth University School of Medicine; Richmond VA USA

2. American University of Beirut Medical Center; Beirut Lebanon

3. University of California, San Francisco; San Francisco CA USA

4. Loyola University of Chicago; Maywood IL USA

5. Mayo Clinic College of Medicine; Rochester MN USA

6. University of Michigan; Ann Arbor MI USA

7. University of Cambridge School of Clinical Medicine; Cambridge UK

8. MD Anderson Cancer Center; Houston TX USA

9. University of Chicago; Chicago IL USA

10. University of Pittsburgh; Pittsburgh PA USA

11. Duke University School of Medicine; Durham NC USA

12. University of Pennsylvania; Philadelphia PA USA

13. The Johns Hopkins Bayview Medical Center; Baltimore MD USA

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.2708/fullpdf

Reference146 articles.

1. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures;Johnell;Osteoporos Int,2006

2. ASBMR Task Force on Secondary Fracture Prevention. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention;Eisman;J Bone Miner Res,2012

3. 2011 http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm270958.pdf

4. FLEX Research Group. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial;Black;JAMA,2006

5. FLEX Research Group. Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial;Schwartz;J Bone Miner Res,2010

Cited by 469 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications;Bone Reports;2024-03

2. Organic Matrices of Calcium Carbonate Biominerals Improve Osteoblastic Mineralization;2024-02-06

3. Review of publications on drug-related problems investigations in osteoporosis patients;Pharmacy & Pharmacology;2024-01-29

4. Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review;The Journal of Clinical Endocrinology & Metabolism;2024-01-10

5. Follow-up bone mineral density testing: 2023 official positions of the International Society for Clinical Densitometry;Journal of Clinical Densitometry;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3